chr17-66641453-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_002737.3(PRKCA):c.387G>A(p.Gly129=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000926 in 1,606,612 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0048 ( 5 hom., cov: 31)
Exomes 𝑓: 0.00052 ( 10 hom. )
Consequence
PRKCA
NM_002737.3 synonymous
NM_002737.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.103
Genes affected
PRKCA (HGNC:9393): (protein kinase C alpha) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This kinase has been reported to play roles in many different cellular processes, such as cell adhesion, cell transformation, cell cycle checkpoint, and cell volume control. Knockout studies in mice suggest that this kinase may be a fundamental regulator of cardiac contractility and Ca(2+) handling in myocytes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 17-66641453-G-A is Benign according to our data. Variant chr17-66641453-G-A is described in ClinVar as [Benign]. Clinvar id is 707964.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.103 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00483 (736/152228) while in subpopulation AFR AF= 0.0166 (691/41530). AF 95% confidence interval is 0.0156. There are 5 homozygotes in gnomad4. There are 362 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 736 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKCA | NM_002737.3 | c.387G>A | p.Gly129= | synonymous_variant | 4/17 | ENST00000413366.8 | NP_002728.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKCA | ENST00000413366.8 | c.387G>A | p.Gly129= | synonymous_variant | 4/17 | 1 | NM_002737.3 | ENSP00000408695 | P1 | |
PRKCA | ENST00000578063.5 | c.387G>A | p.Gly129= | synonymous_variant, NMD_transcript_variant | 4/10 | 1 | ENSP00000462087 | |||
PRKCA | ENST00000284384.6 | c.442G>A | p.Asp148Asn | missense_variant, NMD_transcript_variant | 5/15 | 5 | ENSP00000284384 |
Frequencies
GnomAD3 genomes AF: 0.00485 AC: 737AN: 152110Hom.: 5 Cov.: 31
GnomAD3 genomes
AF:
AC:
737
AN:
152110
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00124 AC: 307AN: 248156Hom.: 1 AF XY: 0.000924 AC XY: 124AN XY: 134136
GnomAD3 exomes
AF:
AC:
307
AN:
248156
Hom.:
AF XY:
AC XY:
124
AN XY:
134136
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000516 AC: 751AN: 1454384Hom.: 10 Cov.: 29 AF XY: 0.000462 AC XY: 334AN XY: 723426
GnomAD4 exome
AF:
AC:
751
AN:
1454384
Hom.:
Cov.:
29
AF XY:
AC XY:
334
AN XY:
723426
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00483 AC: 736AN: 152228Hom.: 5 Cov.: 31 AF XY: 0.00486 AC XY: 362AN XY: 74424
GnomAD4 genome
AF:
AC:
736
AN:
152228
Hom.:
Cov.:
31
AF XY:
AC XY:
362
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at